규제 업데이트

The Korean Pharmacists Association marked the 355th consecutive day of a relay rally in front of the Blue House, urging the government to address licensing issues affecting herbal medicine pharmacists.

Lawmakers and health NGOs held a discussion on improving operating‑room CCTV to protect patient rights, marking ten years since Kwon Dae‑hee’s death.

The KPA’s Emergency Committee held its first operating and execution meetings to plan actions against the government’s push to broaden prescription drug delivery for telemedicine.

The US FDA approved AstraZeneca’s oral SERD camizestrant, branded Etcamah, for HR‑positive/HER2‑negative breast cancer patients with ESR1‑mutated ctDNA detected before radiographic progression, based on the Phase 3 SERENA‑6 trial.

With coverage extending to severe type‑2 diabetes, groups call for a shift from upfront payment to direct co‑payment at pharmacies for CGM and insulin pump devices.

Lawmakers begin a series of government‑question sessions, with pharmacist concerns under watch as the agenda runs through Aug 14.

MFDS announced partial amendments to drug approval regulations, reducing documentation for medical high‑pressure gases and widening multiple‑specification allowances for orphan‑drug active ingredients.

Health officials are checking pharmacy inventories of Paxlovid and pharmacies are securing more supplies, while interest revives in IlDong Pharma's oral antiviral candidate.

Chair Kang Cheong-hee announces AI-driven reforms, electronic prescription system and telemedicine preparations to ensure Korea's health insurance financial sustainability.

The Korean Pharmaceutical Association has launched an emergency committee and announced protests on March 13 and 20 to oppose the government's plan to broaden delivery of prescription drugs for telemedicine.

The Korea Disease Control and Prevention Agency held a symposium in Cheongju to review ten years of Kor-GLASS data and discuss future directions for national AMR response.

Repeated blood in stool warrants testing; Korea will lower screening age from 50 to 45 and replace fecal tests with colonoscopy starting 2028.